Reckitt Benckiser Group plc ("Reckitt") (LSE: RKT) announced today (i) the expiration and results of its wholly-owned ...
Quarterly revenue reaches $3.1 million; first-half revenue increases 57% to $5.5 million Company enters next phase focused on contribution margin improvement, operating ...
Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor recreation product manufacturer, today announced strategic actions to optimize its manufacturing ...
FocalTherics Reports Second Quarter 2026 Financial Results 39% Revenue Increase and 47% Growth in U.S. Procedures AUSTIN, Texas, Aug. 13, 2026 (GLOBE NEWSWIRE) -- FocalTherics (Nasdaq: FOCL) (the "Com ...
Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and ...
Safe Pro Group Inc. (Nasdaq: SPAI) ("Safe Pro" or the "Company"), a developer of artificial intelligence (AI)-enabled defense, security, and situational ...
Records first operating revenue from locking service and Super Validator operations Completes sale of legacy biotechnology subsidiary Gravitas NEW YORK, Aug. 14, 2026 ...
All amounts expressed are in U.S. dollars, denoted by "$".Toronto, Ontario--(Newsfile Corp. - August 14, 2026) - Largo Inc. (TSX: LGO) (NASDAQ: LGO) ("Largo" or the "Company"), the world's largest ...
Solmate Infrastructure PLC (NASDAQ: SLMT) ("Solmate" or the "Company"), a next-generation digital infrastructure company focused on blockchain and staking, is launching a public treasury dashboard ...
Vancouver, British Columbia--(Newsfile Corp. - August 11, 2026) - Kingfisher Metals Corp. (TSXV: KFR) (FSE: 9700) (OTCQB: KGFMF) ("Kingfisher" or the "Company") provides an update on the progress of ...
Key Third Quarter Data Points Revenue of $9.09 million, was roughly flat vs. $9.09 million last year. Growth in our recurring monitoring and services revenue was offset by the delay of a product sale ...
Phase 1 trial evaluating GTB-3650 TriKE- remains ongoing, with an update anticipated in 2H 2026 Phase 1 basket trial evaluating GTB-5550 TriKE- in multiple solid tumor types known to express B7-H3 ini ...